Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy

Circulation Research

Volumn 96, Issue 2, 2005, Pages 225-233

  Chiu, Hsiu Chiang ^a   Kovacs, Attila ^a   Blanton, Robert M ^a   Han, Xianlin ^a   Courtois, Michael ^a   Weinheimer, Caria J ^a   Yamada, Kathryn A ^a   Brunei, Sylvain ^a   Xu, Haodong ^a   Nerbonne, Jeanne M ^a   Welch, Michael J ^b   Fettig, Nicole M ^b   Sharp, Terry L ^b   Sambandam, Nandakumar ^a   Olson, Krista M ^a   Ory, Daniel S ^a   Schaffer, Jean E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Lipids; Metabolism

Indexed keywords

CARBON 14; CARRIER PROTEIN; FATTY ACID TRANSPORT PROTEIN 1; GLUCOSE; LIPID; MYOSIN HEAVY CHAIN ALPHA; PALMITIC ACID; POTASSIUM ION; TRITIUM; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FATTY ACID TRANSPORT; GENE OVEREXPRESSION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE; HOMEOSTASIS; HYPERLIPIDEMIA; ISOLATED HEART; ISOTOPE LABELING; LIPID METABOLISM; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; CARDIOMYOPATHIES; CELL SIZE; DIASTOLE; ELECTROCARDIOGRAPHY; FATTY ACID TRANSPORT PROTEINS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; GLUCOSE; HYPERTROPHY; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; POSITRON-EMISSION TOMOGRAPHY; POTASSIUM CHANNELS, VOLTAGE-GATED; RECOMBINANT FUSION PROTEINS;

EID: 13444268937     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000154079.20681.B9     Document Type: Article

References (46)

1. Galloway JH, Cartwright IJ, Bennett MJ. Abnormal myocardial lipid composition in an infant with type II glutaric aciduria. J Lipid Res. 1987; 28:179-284.
2. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, Davila-Roman VG. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol. 2004;43: 1399-1404.
3. Peterson LR, Herrero P, Schechtman KB, Racette S, Waggoner AD, Kisreiva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109:2191-2196.
4. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 1974;34:29-34.
5. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J. 1989;118: 1000-1012.
6. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98:33-39.
7. Reusch JEB. Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? J Clin Invest. 2003;112: 986-988.
8. Kelly DP, Strauss AW. Mechanisms of disease: inherited cardiomyopathies. N Engl J Med. 1994;330:913-919.
9. Sack MN, Kelly DP. The energy substrate switch during development of heart failure: gene regulatory mechanisms. Int J Mol Med. 1998;1:17-24.
10. Zuniga-Guajardo S, Zinman B. The metabolic response to the euglycemic insulin clamp in type I diabetes and normal humans. Metabolism. 1985; 34:926-930.
11. Fraze E, Donner CC, Swislocki ALM, Chiou YAM, Chen YDI, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1985;61:807-811.
12. Barrett-Connor E, Grundy SM, Holdbrook MJ. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiology. 1982;115:657-663.
13. Zhou Y-T, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA. 2000;97:1784-1789.
14. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes. 2002;51: 2587-2595.
15. Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem. 2002;277: 27014-27020.
16. Bjorkegren J, Veniant M, Kim SK, Withycombe SK, Wood PA, Hellerstein MK, Neese RA, Young SG. Lipoprotein secretion and triglyceride stores in the heart. J Biol Chem. 2001;276:38511-38517.
17. Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S, Goldberg IJ. Lipoprotein lipase (LpL) on the surface of acrdiomyocvtes increases lipid uptake and produces a cardiomyopathy. J Clin Invest. 2003;111: 419-427.
18. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP. The cardiac pheno-type induced by PPARa overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109:121-130.
19. Deleted in proof.
20. Palermo J, Gulick J, Colbert M, Fewell J, Robbins J. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circulation. 1996;787:504-509.
21. Chiu H, Kovacs A, Ford D, Hsu F, Garcia R, Herrero P, Saffitz J, Schaffer J. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2000;107:813-822.
22. Belke DD, Larsen TS, Lopaschuk GD, Severson DL. Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol. 1999;277:R1210-R1217.
23. Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res. 2003;44:1071-1079.
24. Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M, Blumer KJ, Kelly DP, Muslin AJ. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest. 1999;104:567-576.
25. Xu H, Barry DM, Li H, Brunei S, Guo W, Nerbonne JM. Attenuation of the slow component of delayed rectification, action potential prolongation and triggered activity in mice expressing a dominant-negative Kv2a subunit. Cire Res. 1999;85:623-633.
26. Brunet S, Aimond F, Li H, Guo W, Eldstrom J, Fedida D, Yamada KA, Nerbonne JM. Helerogeneous expression of repolarizing, voltage-galed K+ currents in adult mouse ventricles. J Physiol. 2004; 559.1:103-120.
27. Richards MR, Listenberger LL, Kell AA, Lewis SE, Ory DS, Schaffer JE. Oligomerization of the murine fatty acid transDJport protein 1. J Biol Chem. 2003;278:10477-10483.
28. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 1994;79: 427-436.
29. Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med. 1996;37: 1723-1730.
30. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA. 1998;95: 8625-8629.
31. Fitscher BA, Riedel HD, Young KC, Stremmel W. Tissue distribution and cDNA cloning of a human fatty acid transport protein (hsFATP4). Biochim Biophys Acta. 1998;1443:381-385.
32. Gimeno RE, Ortegon AM, Patel S, Punreddy S, Ge P, Sun Y, Lodish HF, Stahl A. Characterization of a heart-specific fatty acid transport protein. J Biol Chem. 2003;278:16039-16044.
33. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E. Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation: homology with human CD36. J Biol Chem. 1993;268: 17665-17668.
34. Nishimura RA, Tajik J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol. 1997;30:8-18.
35. London B, Jeron A, Zhou J, Buckett P, Han X, Mitchell GF, Koren G. Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci USA. 1998;95:2926-2931.
36. Bou-Abboud E, Li H, Nerbonne JM. Molecular diversity of the repolarizing voltage-gated K+ currents in mouse atrial myocytes. J Physiol. 2000;529:345-356.
37. Nerbonne JM, Nichols CG, Schwarz TL, Escande D. Genetic manipulation of cardiac K+ channel function in mice. Circ Res. 2001;89: 944-956.
38. ATP channels. Science. 1998;282:1138-1141.
39. + channel by long chain acyl-CoA. J Biol Chem. 1996;271:10623-10626.
40. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA. 1997; 94:4182-4187.
41. Rossing P, Breum L, Major-Pedersen A, Sato A, Winding H, Pietersen A, Kastrup J, Parving HH. Prolonged QTc interval predicts mortality in patients with type 1 diabetes. Diabet Med. 2001;18:199-205.
42. Linnemann B, Januka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death: The Bremen diabetes study. Exp Clin Endocrinol Diabetes. 2003;111: 215-222.
43. Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol. 2002;283:H976-H982.
44. Christoffersen C, Bollano E, Lindegaard MLS, Bartels ED, Goetze JP, Andersen CB, Nielsen LB. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology. 2003;144: 3483-3490.
45. Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, Tsuji T, Kohzuki H, Suga H, Taniguchi S, Takaki M. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol. 2002; 282:H138-H148.
46. Joffe II, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan JP, Douglas PS. Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol. 1999;34:2111-2119.